Article
Evaluation of in silico tools and Chat-GPT in identifying the impact of missense variants of immune-related genes associated with immunotherapy outcomes for solid tumors
2024-03-26
Abstract excerpt
Understanding clinical significance of variants of unknown significance (VUS) reported in next-generation sequencing (NGS) has become essential in cancer treatment. Our study examined six widely used in silico tools: PolyPhen-2, Align-GVGD, MutationTaster2, CADD, REVEL, and Chat-GPT. We utilized a dataset of gene variants known to potentially affect immune therapy. No single tool could comprehensively determine mu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49c391d2-fdc4-5d80-9b29-1c7318b62995
- DOI
- 10.20944/preprints202403.1496.v1
